Introduction
============

Pain is a complex experience that involves purely sensory aspects, such as nociceptive stimuli, as well as emotional effects and feelings of unease ([@B7]). While pain serves as a warning against noxious stimuli ([@B54]), chronic pain severely decreases quality of life. Also, emotional states heavily influence pain ([@B51]). The severity of psychopathology in patients with major depressive disorder was positively associated with the prevalence of pain ([@B28]). Thus, pain is modulated by both sensory and emotional factors. We previously demonstrated that emotional states altered mechanical allodynia and behavioral responses in mice ([@B40]). Another report showed that exposure to restraint stress before induction of neuropathic pain significantly increased mechanical allodynia ([@B42]). To obviate hyperalgesic effects associated directly with a physical stressor, we chose to use the maternal separation and social interaction (MSSI) stress model, a purely psychological form of stress. The MSSI model shows long-lasting behavioral and pathophysiological impairments ([@B41]). We previously indicated that MSSI exacerbated mechanical allodynia. Interestingly, mice showed sex differences in several anxiety tests following MSSI, while pain was observed in both sexes after MSSI ([@B40]). These findings suggested that differences in sex may influence the relationship between pain control and emotional states.

Accumulating evidence indicates that astrocytes play a crucial role in the regulation of neural function in the central nervous system (CNS). Astrocytes are the most numerous type of glial cell. ([@B50]) and are important regulators of neural activity. For example, they contribute to neurotransmitter uptake and the CNS vascular response to neural activity ([@B47]; [@B17]). Moreover, astrocytes alter neural excitability via direct release of neuromodulator molecules ([@B22]). In fact, astrocytes can release gliotransmitters (e.g., glutamate, GABA, [D]{.smallcaps}-serine, ATP) in response to neuronal activity including increase in the intracellular Ca^2+^ concentration ([@B2]; [@B21]). Exocytotic release of gliotransmitters or channel-mediated release via Ca^2+^-dependent Cl^-^ channel and volume-regulated anion channel ([@B27]; [@B44]) were induced by increase in the cytosolic Ca^2+^ concentration. Furthermore, gliotransmitters can also be released through Ca^2+^-independent opening of P2X purinergic receptors ([@B12]) or connexin/pannexin such as Cx43 hemichannels ([@B37]). These factors can act on receptors on the presynaptic nerve terminal, or on post-synaptic dendrites when gliotransmitters are released from astrocytes. Astrocytes also contribute to the clinical and pathological mechanisms of disease processes. In a chronic pain study, reactive transformation of astrocytes following neuropathic pain contributed to the enhancement of neuropathic pain by releasing growth factors and inflammatory mediators ([@B57]). Further, an astrocyte specific intermediate filament is up-regulated after nerve injury ([@B53]) and matrix metalloproteinase (MMP)-2-cleaved interleukin (IL)-1β induced astrocyte activation in the later phase of neuropathic pain ([@B26]). More recently, glucocorticoid regulation of ATP release from spinal astrocytes underlies diurnal exacerbation of neuropathic mechanical allodynia ([@B30]). Based on these reports, it is thought that astrocytes may play a role in modulation of pain.

On the other hand, astrocytes may influence neural networks that underlie specific behaviors, including aberrant behaviors associated with stress. For example, [@B10], showed that glial dysfunction causes depressive-like behaviors and sleep disturbance. Chronic restraint stress causes dysfunction of astrocytes ([@B23]). [@B56], showed that Chronic corticosterone exposure reduces hippocampal astrocyte structural plasticity in mice. A postmortem study reported that levels of glial fibrillary acidic protein (GFAP), a marker of reactive astrocytes, decreased in multiple brain regions in mood disorder patients ([@B35]; [@B6]; [@B4]; [@B9]; [@B15]). Although the mechanisms underlying emotional dysfunction mediated by astrocytes are unclear, these findings suggest that astrocytic abnormalities are associated with stress. In addition, astrocytes are regulated by sex hormones ([@B48]), indicating that there are sex differences in astrocytic function. We hypothesized that astrocytes are involved in sex-dependent emotional dysfunction induced by MSSI.

To examine our hypothesis, we investigated the influence of MSSI on GFAP expression levels and associated nociception and emotion in neuropathic pain states. Furthermore, to evaluate the involvement of local astrocytic activation, we developed a local activation model involving microinjection of supernatant from lipopolysaccharide (LPS)-treated astrocytes.

Materials and Methods {#s1}
=====================

Animals
-------

Pregnant ddY mice at gestational day 14 and timed-pregnant Wister rats (day 16 or 17) and were obtained from Japan SLC, Inc. (Hamamatsu, Japan). The pregnant mice and rat were housed individually under standard conditions (23--24°C, 12 h light/dark cycle with lights on from 8 a.m. to 8 p.m.) with food and water available ad libitum. The present study was conducted in accordance with the Guiding Principles for the Care and Use of Laboratory Animals adopted by the Japanese Pharmacological Society. The Ethical Committee for Animal Experimentation of Kobe Gakuin University approved all experiments (approval number A15-33; Kobe, Japan).

Maternal Separation Combined with Social Isolation Stress Paradigm
------------------------------------------------------------------

Maternal separation combined with social isolation was performed as previously described ([@B40]). Pups both MSSI and control groups were housed with dams until postnatal day 14. On postnatal day 15, the pups in the MSSI group were placed in individual isolation cages (25 cm × 15 cm × 13 cm) for 6 h/day. The isolation cage was surrounded by the black paper to shut out visualization of other. After maternal separation for 7 days, pups were kept in isolation cages until 12 weeks of age. Dams and pups assigned to the control group were reared in standard conditions without maternal separation until weaning. After weaning, the control pups were separated by sex and housed 2--4 per cage.

Elevated Plus-Maze Test
-----------------------

The elevated plus-maze (EPM) test was performed as previously described ([@B40]). Mice were placed on the EPM consisted of two open arms and two enclosed arms (both 25 cm length × 8 cm width) which elevated 50 cm above the floor. The illumination levels of the open and enclosed arms were similar (approximately 360 lx). The behavior was tracked for 5 min by using a web camera. The number of entries to the open arms was expressed as a percentage of enties to all arms. The time spent in the open arms was expressed as a percentage of times in the open arms. A decreased the number of entry and the time spent to the open arms indicaeted anixis-behavior ([@B40]).

Partial Sciatic Nerve Ligation (PSL)
------------------------------------

Mice were deeply anesthetized with sodium pentobarbital (65 mg/kg), and then surgery was performed as previously described at 9 weeks of age ([@B49]). In brief, the sciatic nerve of the right hind limb was exposed through a small incision. Half or two-thirds of the nerve thickness was tightly ligated with a silk suture. In sham-operated mice, the sciatic nerve was exposed without ligation.

von Frey Test
-------------

Mechanical allodynia after nerve injury was measured using the von Frey test as previously described ([@B40]). Mice were placed on a 5 mm × 5 mm wire mesh grid floor for 2--3 h prior to testing. The middle of the plantar surface of each hind paw was probed with 0.4 g von Frey filaments (Neuroscience, Inc., Tokyo, Japan). The withdrawal response to probing of the hind paw was measured 10 times. The intertrial interval was \>10 s. An increase in the number of withdrawals indicates the degree of pain associated with mechanical stimulation ([@B40]).

Immunoflurorescence
-------------------

Immunofluorescence staining was performed as previously described ([@B38]) with some modifications. Mice were deeply anesthetized with diethyl ether and perfused transcardially with phosphate-buffered saline (PBS, pH 7.4) followed by 4% paraformaldehyde in 0.1 M PBS, pH 7.4. After perfusion, brain sections were incubated in 10% sucrose at 4°C for 3 h, and were kept 20% sucrose at 4°C overnight. Sections were cut at 20 μm on a cryostat (CM1850, Leica, Microsystems GmbH, Wetzlar, Germany). The brain sections were incubated with blocking buffer (3% BSA in PBST) for 1 h at room temperature, and then incubated overnight at 4°C with a mouse monoclonal anti-GFAP antibody (MAB3402, Merck Millipore KGaA, Darmstadt, Germany; 1:1000) and chicken polyclonal anti- tyrosine hydroxylase (TH) (Abcam, Tokyo, Japan; 1:200). The slices were incubated at room temperature for 2 h in secondary antibody (goat polyclonal anti-mouse IgG conjugated with AlexaFluor 488 or 594, goat polyclonal anti-chicken IgG conjugated with AlexaFluor 594; Life Technologies, Inc., Carlsbad, CA, United States; 1:200). The positive cells were detected with a confocal fluorescence microscope (FV1000, Olympus Corporation, Tokyo, Japan) or BZ-X710 microscope (Keyence, Itasca, IL, United States). Reactive astrocytes are characterized by cellular hypertrophy, hyperplasia, immunoreactivity of increased GFAP on tissue slides. The immunoreactivity of GFAP-positive astrocytic cells were quantified with the Image J cell counter analysis tool (ImageJ; NIH, Bethesda, MD, United States) in defined area of interest on the locus coeruleus (LC). The score was blinded to sampling times and animal treatments.

Preparation of Primary Cultured Astrocytes from Rat Brain
---------------------------------------------------------

Astrocytes were prepared from the cerebra of 1- to 2-day-old Wistar rats as described ([@B29]). The isolated cells were seeded at 1 × 10^4^ cells/cm^2^ in 75 cm^2^ culture flasks and grown in minimal essential medium supplemented with 10% fetal bovine serum. To remove small process-bearing cells (mainly oligodendrocyte progenitors and microglia from the protoplasmic cell layer), the culture flasks were shaken at 250 rpm overnight 10--14 days after seeding. The monolayer cells were trypsinized and seeded on six-well culture plates or on 15 mm glass cover slips in 24-well culture plates. At this stage, approximately 95% of the cells showed immunoreactivity for GFAP.

Lipopolysaccharide (LPS) Stimulation of Rat Astrocytes
------------------------------------------------------

Before treatment, astrocytes in six well-culture plates were incubated in serum-free medium for 48 h. LPS was minimally diluted using serum-free medium before treatment. After incubation in serum-free medium, the cells were treated with 1,000 ng/mL LPS for 24 h.

Microinjection of Astrocyte Supernatant
---------------------------------------

Microinjection of astrocyte culture supernatant into the LC was performed as previously described ([@B38]), with some modifications. Briefly, mice were anesthetized with pentobarbital (65 mg/kg) and immobilized on a stereotaxic frame (SR-5M; NARISHIGE, Co., Ltd, Tokyo, Japan). A microsyringe with a 30-gauge stainless steel needle was inserted unilaterally into the LC (5.4 mm posterior to bregma, 0.9 mm lateral from the midline, and 4.0 mm deep) and astrocyte supernatant (0.2 μL) injected incrementally over 1 min (**Figure [3A](#F3){ref-type="fig"}**). The injection site in LC was confirmed using 0.5% Trypan blue in saline.

Statistical Analyses
--------------------

All data are expressed as the mean ± the standard error of the mean (SEM). Significant differences were determined by a one-way analysis of variance (ANOVA) followed by Scheffe's multiple comparison tests (for comparisons between more than three groups) or Student's *t*-test (for comparisons between two groups). A *P*-value \< 0.05 was considered significant.

Results
=======

MSSI Stress Induced an Increase in GFAP Protein Expression in the LC Area of Female But Not Male Mice
-----------------------------------------------------------------------------------------------------

Immunoreactivity for GFAP was observed surrounding TH positive cells in the LC. In males, MSSI stress did not affect GFAP expression in the LC at 7 weeks of age, before PSL (**Figures [1A,B](#F1){ref-type="fig"}**). In contrast, MSSI stress induced a significant increase in GFAP expression in the LC of female mice, compared to control female mice, at 7 weeks of age (**Figures [1C,D](#F1){ref-type="fig"}**).

![Maternal separation combined with social isolation (MSSI) stress induced an increase in GFAP protein expression in the LC area of female but not male mice. Representative images showing immunofluorescence labeling of GFAP (green) and TH (Red) in the LC of MSSI stressed mice at 7 weeks of age, before PSL. Percentage of the GFAP positive area over the total area including LC after MSSI in **(A,B)** male mice and **(C,D)** female mice. Panel shows representative images of the GFAP positive area. Results expressed as percent of Control (mean ± SEM) from *n* = 3 male mice and *n* = 3 female mice. ^\#^*P* \< 0.05, vs. Control, Student's *t*-test. Scale bar = 100 mm. LC, locus coeruleus.](fphar-08-00401-g001){#F1}

The MSSI-Induced Increase in LC GFAP Expression Was Suppressed by PSL in Female Mice
------------------------------------------------------------------------------------

At 12 weeks of age, the increased GFAP protein expression was observed in brain regions including the LC of MSSI-stressed female mice, compared to control female mice. This MSSI-induced increase in LC GFAP expression was suppressed by PSL (**Figures [2A,B](#F2){ref-type="fig"}**). In other region of the brain, GFAP protein expression did not change in male and female mice (Supplementary Figure [1](#SM1){ref-type="supplementary-material"}).

![The MSSI-induced increase in LC GFAP expression was suppressed by PSL in female mice. Representative images showing immunofluorescence labeling of GFAP (green) and TH (Red) in the LC of mice **(A)**. Percentage of the GFAP positive area over the total area including LC of MSSI stressed mice at 12 weeks of age, after PSL after PSL **(B)**. Panel shows representative images of the GFAP positive area. Results expressed as percent of Control (mean ± SEM in female mice: *n* = 3) **(C)**. ^∗^*P* \< 0.01 vs. Control-Sham, vs. Control-PSL, vs. Stress-PSL, Scheffe's test. Scale bar = 100 mm. LC, locus coeruleus.](fphar-08-00401-g002){#F2}

LPS-Treated Astrocyte-Conditioned Medium Microinjection into the LC Induced Increased GFAP Expression in Male and Female Mice
-----------------------------------------------------------------------------------------------------------------------------

In male and female mice, microinjection of LPS-treated astrocyte-derived supernatant into the brainstem area, including the LC, significantly increased local GFAP expression compared to non-treated control medium (**Figures [3B](#F3){ref-type="fig"}--[E](#F3){ref-type="fig"}**). GFAP positive cells were observed surrounding TH positive cells in the LC (**Figure [3F](#F3){ref-type="fig"}**).

![Lipopolysaccharide (LPS)-treated astrocyte-conditioned medium microinjection into the LC increased GFAP expression in male and female mice. **(A)** Schematic diagram of the experimental protocol for microinjection into the LC. LC, locus coeruleus. Representative images showing immunofluorescence labeling of GFAP (red) in the LC of mice. **(A)** Percentage of the GFAP positive area over the total area including LC after microinjection in male **(B,C)** and female **(D,E)** mice. GFAP (Red) ^∗^*P* \< 0.05, vs. Media, Student's *t*-test. Representative images showing immunofluorescence labeling of GFAP (green) and TH (Red) in the LC of mice **(F)**. Representative images of astrocytes in LC after microinjection. GFAP (Green), TH (Red). Scale bar = 100 mm.](fphar-08-00401-g003){#F3}

LPS-Treated Astrocyte-Conditioned Medium Microinjection into the LC Induced Anxiety-Like Behavior and PSL-Induced Mechanical Allodynia in Male Mice
---------------------------------------------------------------------------------------------------------------------------------------------------

In male mice, microinjection of LPS-treated astrocyte-derived supernatant into the brainstem area, including the LC, significantly decreased the number of open arm crossings and time spent in the open arms compared to vehicle-treated male mice (**Figures [4A,B](#F4){ref-type="fig"}**). In contrast, there was no difference in the number of center zone crossings between vehicle- and LPS-treated groups (**Figure [4C](#F4){ref-type="fig"}**). The entries into open arms (%) or the time spent in open arms (%) correlated negatively with the response time to mechanical stimuli after PSL in vehicle- or LPS-treated male mice (**Figure [4D](#F4){ref-type="fig"}**). At 1 week after PSL, the vehicle- and LPS-treated astrocyte-derived supernatant treated mice showed an increased number of responses to mechanical stimuli compared to vehicle- and LPS-treated injected sham injured male mice. Mice injected with LPS-treated astrocyte-derived supernatant showed a tendency toward an increase in the number of responses to mechanical stimuli compared to vehicle-treated injected PSL male mice. However, the number of responses against mechanical stimuli did not change between the vehicle treated group and the LPS-treated astrocyte-derived supernatant group prior to PSL (**Figure [4E](#F4){ref-type="fig"}**).

![Lipopolysaccharide-treated astrocyte-conditioned medium microinjection into the LC induced anxiety-like behavior and PSL-induced mechanical allodynia in male mice. **(A)** The number of entries into open arms (%). **(B)** Time spent in the open arms (%). **(C)** The total number of entries into the four arms. Vehicle group: *n* = 8, Treated group: *n* = 9. **(D)** Correlation between the entries into open arms (%) or the time spent in open arms (%) and mechanical stimuli after PSL in vehicle- or LPS-treated male mice. **(E)** 0.4 g filament. Vehicle-Sham group: *n* = 5, Vehicle-PSL group: *n* = 6, Treated-Sham group: *n* = 5, Treated-PSL group: *n* = 11. Data expressed as the mean ± SEM. ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01 vs. Vehicle, Student's *t*-test. ^\#^*P* \< 0.05 vs. Vehicle + Sham, ^†^*P* \< 0.05 vs. Treated + Sham, Scheffe's test.](fphar-08-00401-g004){#F4}

LPS-Treated Astrocyte-Derived Supernatant Microinjection into the LC Caused Anxiety-Like Behavior and PSL-Induced Mechanical Allodynia in Female Mice
-----------------------------------------------------------------------------------------------------------------------------------------------------

Similar results were obtained in female mice. Female mice microinjected with LPS-treated astrocyte-derived supernatant showed a decreased number of open arm crossings and time spent in the open arms compared to vehicle-treated female mice (**Figures [5A,B](#F5){ref-type="fig"}**). The number of crossings in the center zone was comparable to that in vehicle-treated female mice (**Figure [5C](#F5){ref-type="fig"}**). The entries into open arms (%) or the time spent in open arms (%) correlated negatively with the response time to mechanical stimuli after PSL in vehicle- or LPS-treated female mice (**Figure [5D](#F5){ref-type="fig"}**). At 1 week after PSL, vehicle- and LPS-treated astrocyte-derived supernatant female mice showed an increased number of responses to mechanical stimuli compared to vehicle- and LPS-treated supernatant- injected female mice. Furthermore, the number of responses to mechanical stimuli showed a significant increase in LPS-treated PSL female mice compared to vehicle-treated PSL female mice. In contrast, the number of responses to mechanical stimuli before PSL was similar in both vehicle- and LPS-treated supernatant-injected female mice (**Figure [5E](#F5){ref-type="fig"}**).

![Lipopolysaccharide-treated astrocyte-derived supernatant microinjection into the LC caused anxiety-like behavior and PSL-induced mechanical allodynia in female mice. **(A)** The number of entries into open arms (%). **(B)** Time spent in the open arms (%). **(C)** The total number of entries into the four arms. Vehicle group: *n* = 8, Treated group: *n* = 11. **(D)** Correlation between the entries into open arms (%) or the time spent in open arms (%) and mechanical stimuli after PSL in vehicle- or LPS-treated female mice. **(E)** 0.4 g filament. Vehicle-Sham group: *n* = 4, Vehicle-PSL group: *n* = 7, Treated-Sham group: *n* = 6, Treated-PSL group: *n* = 10. Data expressed as mean ± SEM. ^∗∗^*P* \< 0.01 vs. Vehicle, Student's *t*-test. ^\#^*P* \< 0.05 vs. Vehicle + Sham, ^††^*P* \< 0.01 vs. Treated + Sham, ^x^*P* \< 0.05 vs. Treated + PSL, Scheffe's test.](fphar-08-00401-g005){#F5}

Discussion
==========

Both the LC in the pons and the rostral ventromedial medulla (RVM) contribute to the regulation of pain and emotion ([@B3]; [@B55]). Noradrenergic and serotonergic neurons are localized to the LC and RVM, respectively, and project to multiple higher brain areas as well as to the spinal cord. The descending pathways regulate nociceptive signaling in the spinal cord. It has been reported that chronic stress activates or suppress neuronal activity in the LC, and neuropathic pain suppress neuronal activity in the LC, which is associated with the development of anxiety-like behaviors in mice ([@B5]). Selective depletion of noradrenaline in the LC causes anxiety- and depression-like behaviors ([@B24]). Physiological changes in glial cells of the medulla oblongata are associated with disease states and altered neuronal activity ([@B1]; [@B43]). For example, downregulation of astrocytic gene expression was observed in the postmortem LC of major depressive disorder patients ([@B8]). Chronic restraint stress decreased the expression of GFAP and S100β calcium-binding protein in the cytoplasm of astrocytes ([@B14]) in the RVM ([@B23]), while inflammation-induced reactive astrocytes enhanced the activity of the serotonergic descending pain facilitation system, which increased nociceptive signaling in the spinal cord via the RVM ([@B11]; [@B46]). In this study, we examined the influence of MSSI on astrocytes in the LC to determine whether astrocytes were involved in the exacerbation of neuropathic pain by emotional dysfunction. We found that MSSI significantly increased GFAP expression in the LC of female but not male mice. Furthermore, we found that GFAP expression in the medulla oblongata of MSSI stressed female mice shows tendency of increase at 12 weeks age, but not male mice (Supplementary Figures [1](#SM1){ref-type="supplementary-material"}, [2](#SM1){ref-type="supplementary-material"}). It is well-known that up-regulation of GFAP levels is associated with functional changes in astrocytes that in turn affect neuronal function, due to changes in astrocyte-neuron signaling ([@B16]). Therefore, these findings suggest that MSSI-induced dysfunctional astrocytes in the LC are involved in the development of abnormal emotional states and alterations of the pain modulatory system.

Our previous results demonstrated that MSSI increased anxiety-like behaviors in female but not male mice ([@B40]) and MSSI did not influence GFAP expression in the LC of male mice. However, [@B41] previously found that MSSI increased EPM anxiety-like behavior in both male and female C57BL/6J mice. In mice, anxiety and depression-like behaviors differ according to strain or sex ([@B36]; [@B34]). Generally, females have increased stress sensitivity, likely due to differences in sex hormones, although the detailed mechanisms are not clear ([@B33]). As show in **Figures [1](#F1){ref-type="fig"}**, **[2](#F2){ref-type="fig"}**, at 7 or 12 weeks age, the GFAP expression in the LC of MSSI stressed mice with or without PSL treated was different between male and female. These results indicate that MSSI-mediated emotional dysfunction and neuropathic pain exacerbation might be more sensitively induced or worked astrocyte activation in female stressed mice, but not male stressed mice. Therefore, our findings suggest that sex differences in LC astrocytic activation induced by MSSI are responsible, at least in part, for the sex differences in anxiety-like behavior and are mediated through the damaging effects of reactive astrocytes on female LC neurons.

Furthermore, to investigate the effect of acute and region-selective activation of LC astrocytes on anxiety-like or nociceptive behaviors, we microinjected the supernatant of LPS-treated astrocytes into the LC region. We found that LC astrocytes up-regulated GFAP expression and showed morphological changes, indicating that astrocytes were activated by the supernatant injection. LPS binds to toll like receptor (TLR) 4, which is expressed in astrocytes. It is thought that these signaling-induced inflammatory responses, which are mediated by the NF-κB pathway, may result in activation of astrocytes ([@B18]; [@B32]). Activated astrocytes show up-regulated GFAP protein levels and morphological changes, such as cellular hypertrophy and outgrowth of astrocytic foot processes ([@B52]; [@B45]). In this study, we used the LPS-treated astrocytes from rat cell culture. As shown in previous reports, co-culture systems have been used which combined rat astrocytes with mouse neurons. And also, it is reported that rat astrocytes provided optimum conditions for synaptic functioning of mouse neurons ([@B19]). Further, it is reported that there was no cross-reactivity toward mouse-derived embryonic stem cells injected into rat retina ([@B20]). In this study, microinjection of supernatant from vehicle-treated astrocytes was not affected GFAP expression in the LC area. Based on these reports, we believe that cross-reactivity which may be induced by the microinjection of supernatant from rat astrocytes into mice may have a negligible effect on GFAP protein expression.

The important point is that LC administration of supernatant derived from LPS-treated astrocytes increased anxiety-like behavior and GFAP expression in both male and female mice. These results indicate that activation of astrocytes in the LC might result in emotional dysfunction and exacerbated mechanical allodynia. However, the GFAP expression in the LC of MSSI mice with PSL was different between males and females. We previously showed that MSSI sex-dependently induced emotional dysfunction after nerve injury, which was associated with sex differences in the stress-induced regulation of BDNF expression ([@B39]). It is thought that neuronal function in the brain of male mice is protected from early life stresses, such as MSSI, by altered expression of several stress-responsive factors, including BDNF upregulation, such that MSSI male mice might acquire resistance to stress. Our findings suggest that activation of astrocytes in the LC, caused by MSSI, might be involved in the induction of emotional dysfunction.

We also found that LC astrocytic dysfunction caused by MSSI contributes to the exacerbation of mechanical allodynia after PSL. Despite downregulation of MSSI-induced LC GFAP overexpression by PSL, MSSI enhanced nerve injury-induced mechanical allodynia. Many studies on the relationship between pain and astrocytic function have demonstrated that inflammation or nerve injury activates astrocytes in the spinal cord and supraspinal area, and that these activated cells contribute to the development and maintenance of persistent pain ([@B25]). Previous studies have also shown that anti-inflammatory drugs, such as steroids, suppress activated astrocytes ([@B31]; [@B13]). The MSSI-induced increase in GFAP expression was reversed to control levels by PSL, which would appear to be an improvement in the MSSI effect. From our results, it is unclear whether PSL-induced downregulation of LC GFAP expression in MSSI-stressed mice is associated with the exacerbation of nerve injury-induced mechanical allodynia. We suggest that the MSSI-induced increase in LC GFAP expression in the absence of nerve injury may induce a reduction in mechanical threshold in the presence of nerve injury. The activated astrocytes produce various neurotrophic factors, cytokines, chemokines, and free radicals, with both neuroprotective and neurotoxic effects. The balance between these factors is important for preservation of neuronal function and may act to trigger a compensatory condition against MSSI. Nerve injury may shift this balance and thereby enhance mechanical allodynia.

Furthermore, as shown in **Figures [4](#F4){ref-type="fig"}**, **[5](#F5){ref-type="fig"}**, we found that activation of astrocytes which induced by microinjection of astrocyte conditioned medium with LPS caused emotional dysfunction and exacerbated mechanical allodynia. On the other hand, there is no increased GFAP expression following MSSI in male mice although MSSI-mediated neuropathic pain exacerbation observed in male mice ([@B39]). This discrepancy between male and female indicates that other factors which inhibit astrocyte activation may be produced in MSSI stressed male mice, but not female stressed mice. Further studies will be needed to clarify sex difference between astrocyte activation and pain.

Conclusion
==========

We found that MSSI sex-dependently activated astrocytes in the LC, as indicated by increased GFAP expression, with increases in anxiety-like behavior. These MSSI-induced activated astrocytes in the LC may contribute to the exacerbation of neuropathic pain. Furthermore, male mice, but not female mice, might acquire resistance to MSSI-induced stress during growth. We have thus identified one possible and unexpected mechanism linking emotional state with changes in the pain control system, i.e., astroglial activation in the LC.
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